Genetically engineered nanocarriers for drug delivery
Pu Shi, Joshua A Gustafson, J Andrew MacKayDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USAAbstract: Cytotoxicity, low water solubility, rapid clearance from circulation, and off-target side-effects are common drawbacks of conventional...
Guardado en:
Autores principales: | Shi P, Gustafson JA, MacKay JA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fef916374b941caa6d78bd54248732c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Physicochemical characterization of drug nanocarriers
por: Manaia EB, et al.
Publicado: (2017) -
Advances in nanocarriers as drug delivery systems in Chagas disease
por: Quijia Quezada C, et al.
Publicado: (2019) -
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
por: Malgorzata Smola, et al.
Publicado: (2008) -
Drug delivery and nanoparticles: Applications and hazards
por: Wim H De Jong, et al.
Publicado: (2008) -
The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies
por: Chenel V, et al.
Publicado: (2015)